Kendall Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$560K Hold
8,007
0.15% 140
2025
Q1
$589K Buy
8,007
+4,146
+107% +$305K 0.17% 137
2024
Q4
$253K Sell
3,861
-25
-0.6% -$1.64K 0.07% 194
2024
Q3
$303K Sell
3,886
-25
-0.6% -$1.95K 0.09% 183
2024
Q2
$305K Sell
3,911
-50
-1% -$3.9K 0.1% 172
2024
Q1
$268K Buy
3,961
+620
+19% +$42K 0.09% 185
2023
Q4
$225K Sell
3,341
-25
-0.7% -$1.68K 0.09% 193
2023
Q3
$228K Hold
3,366
0.1% 178
2023
Q2
$241K Sell
3,366
-275
-8% -$19.7K 0.11% 176
2023
Q1
$253K Hold
3,641
0.12% 161
2022
Q4
$247K Sell
3,641
-50
-1% -$3.39K 0.12% 158
2022
Q3
$202K Sell
3,691
-100
-3% -$5.47K 0.12% 164
2022
Q2
$250K Hold
3,791
0.14% 149
2022
Q1
$251K Sell
3,791
-108
-3% -$7.15K 0.12% 155
2021
Q4
$227K Sell
3,899
-92
-2% -$5.36K 0.11% 156
2021
Q3
$240K Buy
3,991
+106
+3% +$6.37K 0.13% 144
2021
Q2
$233K Buy
+3,885
New +$233K 0.13% 140
2020
Q4
Sell
-3,885
Closed -$213K 127
2020
Q3
$213K Sell
3,885
-1,250
-24% -$68.5K 0.19% 115
2020
Q2
$272K Hold
5,135
0.26% 97
2020
Q1
$229K Hold
5,135
0.26% 92
2019
Q4
$256K Sell
5,135
-220
-4% -$11K 0.2% 105
2019
Q3
$239K Sell
5,355
-625
-10% -$27.9K 0.21% 104
2019
Q2
$247K Sell
5,980
-285
-5% -$11.8K 0.22% 105
2019
Q1
$253K Sell
6,265
-350
-5% -$14.1K 0.24% 97
2018
Q4
$251K Sell
6,615
-450
-6% -$17.1K 0.26% 92
2018
Q3
$280K Sell
7,065
-3,600
-34% -$143K 0.24% 96
2018
Q2
$374K Sell
10,665
-5,150
-33% -$181K 0.33% 82
2018
Q1
$553K Sell
15,815
-200
-1% -$6.99K 0.48% 66
2017
Q4
$556K Buy
+16,015
New +$556K 0.49% 64